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Acute imaging does not improve ASTRAL score’s accuracy despite having a
prognostic value
George Ntaios1*†, Vasileios Papavasileiou1†, Mohamed Faouzi2, Peter Vanacker3,
Max Wintermark4, and Patrik Michel5
Background The ASTRAL score was recently shown to reliably
predict three-month functional outcome in patients with acute
ischemic stroke.
Aim The study aims to investigate whether information from
multimodal imaging increases ASTRAL score’s accuracy.
Methods All patients registered in the ASTRAL registry until
March 2011 were included. In multivariate logistic-regression
analyses, we added covariates derived from parenchymal, vas-
cular, and perfusion imaging to the 6-parameter model of the
ASTRAL score. If a specific imaging covariate remained an
independent predictor of three-month modified Rankin
score > 2, the area-under-the-curve (AUC) of this new model
was calculated and compared with ASTRAL score’s AUC. We
also performed similar logistic regression analyses in arbi-
trarily chosen patient subgroups.
Results When added to the ASTRAL score, the following
covariates on admission computed tomography/magnetic
resonance imaging-based multimodal imaging were not
significant predictors of outcome: any stroke-related acute
lesion, any nonstroke-related lesions, chronic/subacute stroke,
leukoaraiosis, significant arterial pathology in ischemic terri-
tory on computed tomography angiography/magnetic reso-
nance angiography/Doppler, significant intracranial arterial
pathology in ischemic territory, and focal hypoperfusion on
perfusion-computed tomography. The Alberta Stroke Program
Early CT score on plain imaging and any significant
extracranial arterial pathology on computed tomography
angiography/magnetic resonance angiography/Doppler were
independent predictors of outcome (odds ratio: 0·93, 95% CI:
0·87–0·99 and odds ratio: 1·49, 95% CI: 1·08–2·05, respectively)
but did not increase ASTRAL score’s AUC (0·849 vs. 0·850, and
0·8563 vs. 0·8564, respectively). In exploratory analyses in sub-
groups of different prognosis, age or stroke severity, no covari-
ate was found to increase ASTRAL score’s AUC, either.
Conclusions The addition of information derived from multi-
modal imaging does not increase ASTRAL score’s accuracy to
predict functional outcome despite having an independent
prognostic value. More selected radiological parameters
applied in specific subgroups of stroke patients may add prog-
nostic value of multimodal imaging.
Key words: ASTRAL score, CT angiography, CT, functional outcome,
multimodal imaging, perfusion CT
Introduction
Multimodal imaging (MMI) of acute ischemic stroke (AIS)
including noninvasive arterial and perfusion imaging shows
promise to improve stroke diagnosis, prognosis, and treatment
selection of AIS patients (1–3). With regard to prognosis, the
value of the presence, site and extent of arterial occlusion (4–6), of
the infarct core (7–9), and of penumbra (8–10) have been shown
to be useful for prediction of stroke outcome in selected patient
populations.
The ASTRAL score was introduced recently for the prognosis of
functional outcome in patients with AIS (11). It is based on six
nonradiological items readily available upon arrival of the stroke
patient in the emergency department (11). It has been externally
validated in three independent and ethnically diverse cohorts,
showing remarkable consistency on predicting three-month
functional outcome (11,12); recently, it was also validated exter-
nally for the prognosis of five-year dependence and mortality
(13). Other scores have also been introduced to predict ischemic
stroke outcome like the PLAN (14), the iSCORE (15), the SSV
(16), the MOSAIC (17), and others (18–22). Most, but not all
(17), of these current stroke outcome scores omit imaging tech-
nology to remain simple and rapid (11). This is especially the case
for the ASTRAL score which can be easily calculated at bedside
without any mathematical calculation by using the color chart
which may be found in the original publication of the score (11).
The aim of the present study was to investigate whether the
addition of information from multimodal imaging increases
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ASTRAL score’s prognostic accuracy to predict three-month
functional outcome in patients with acute ischemic stroke.
Patients and methods
Data selection
All patients who were admitted with AIS between January 2003
and March 2011 and had a prestroke modified Rankin Scale score
(mRS) ≤ 2 were selected from the Acute STroke Registry and
Analysis of Lausanne (ASTRAL). ASTRAL is the prospective reg-
istry of all AIS patients admitted to the stroke unit and/or inten-
sive care unit of the Lausanne University Hospital (CHUV)
within 24 h after last proof of well-being (23). Patients with
missing three-month mRS and one or more missing compo-
nent(s) needed to calculate the ASTRAL score were excluded from
the analysis. Τhe scientific use of the data registered in ASTRAL
was approved by the ethics commission (subcommision III) for
research on humans of the Canton of Vaud.
As previously described (23), the ASTRAL score was calculated
based on age (1 point for every five-years), stroke severity [1 point
for every point of National Institutes of Health Stroke Scale score
(NIHSS) at admission], time delay between symptom onset and
admission (2 points if >three-hours), presence of any new visual
field defect (2 points), glucose at admission (1 point if
>7·3 mmol/l or <3·7 mmol/l), and level of consciousness (3
points if impaired item 1a on the NIHSS was >0) (11).
The methods applied to collect and register data, the defini-
tions used in the ASTRAL registry, and the imaging protocols
for acute ischemic stroke in our center were previously
described (23). With regard to acute MMI, for all patients,
parenchymal imaging [mostly computed tomography (CT)] was
analyzed if performed within 24 h after stroke onset. The pres-
ence of early ischemic changes, the Alberta Stroke Program
Early CT score (ASPECTS) (24), the presence of chronic/
subacute stroke and of leukoaraiosis [Blenow grade 1 or more
(25)] were registered. Acute vascular imaging [mostly CT
angiography (CTA)] within the first 24 h after stroke onset was
analyzed and classified in significant arterial pathology in extra-
and intracranial arteries. Arterial pathology was considered sig-
nificant if occlusion, >50% stenosis, or any signs of dissection
were present; these parameters were combined into a single cat-
egory to simplify their use in clinical practice and increase the
statistical power of the study. Also, perfusion CT (PCT) was per-
formed in most patients with symptoms not clinically limited to
the posterior fossa, according to methods described elsewhere
(26,27). The presence of focal hypoperfusion on visually
inspected slices of cerebral blood flow measurement (corre-
sponding to the combination of infarct core and penumbra) was
noted as present or absent. Threshold maps for core and pen-
umbra were not calculated for this project. All patients were
treated according to current European Stroke Organization
guidelines (28). Unfavorable functional outcome was defined as
three-month mRS > 2.
Statistical analysis
To investigate the prognostic accuracy of the ASTRAL score to
predict three-month functional outcome, we assessed the dis-
criminatory power of the score, i.e., the degree to which the prog-
nostic score enables the discrimination between patients with
favorable and unfavorable outcome by calculating the area-
under-the-curve (AUC).
To assess if a specific imaging covariate increases the prog-
nostic accuracy of the ASTRAL score, we first performed a mul-
tivariate logistic regression analysis with the specific imaging
covariate added in the 6-parameter model of the ASTRAL score
(i.e., age, NIHSS score, onset-to-admission time interval, visual
field defect, glucose and level of consciousness). In case that a
specific imaging covariate remained an independent predictor of
three-month functional outcome, the AUC of this new model
(i.e., the ASTRAL score plus the specific imaging covariate) was
calculated and compared with the AUC of the 6-parameter
model of the ASTRAL score. A specific covariate would be con-
sidered that it increases the prognostic accuracy of the ASTRAL
score if the AUC of the new model was significantly higher than
the AUC of the ASTRAL score. The statistical comparison of
the AUCs was performed with the DeLong method (29). The
imaging covariates included in the multivariate logistic regres-
sion analyses were the following: any stroke-related acute lesion
on CT or magnetic resonance imaging (MRI), the ASPECTS,
any vascular lesions on acute CT or MRI not related to the
current stroke (i.e., chronic or subacute stroke or leukoaraiosis),
chronic or subacute stroke on acute CT or MRI, leukoaraiosis,
focal hypoperfusion on PCT, significant arterial pathology in the
ischemic territory in acute CTA or magnetic resonance angiog-
raphy (MRA) or Doppler, significant intracranial arterial pathol-
ogy in the ischemic territory in acute CTA or MRA or Doppler,
and significant extracranial arterial pathology in the ischemic
territory in acute CTA or MRA or Doppler. The ASPECTS was
analyzed both as continuous and categorical covariate using dif-
ferent arbitrary cutoffs to reduce the possibility of a type II error
(false negative result).
We also investigated whether imaging increased the prognostic
accuracy of the ASTRAL score in specific patient subgroups.
Hence we performed similar logistic regression analyses in arbi-
trarily chosen subgroups of patients with regard to their age (<71
and ≥71 years), NIHSS at admission (≤3, 4–19, and >19), and
ASTRAL score (0–22, 23–38, and >38).
For continuous variables, data are summarized as medians and
interquartile range (IQR). Categorical data are presented as abso-
lute numbers and percentage. Imputation techniques were not
implemented for missing data. In the multivariate analyses, the
level of statistical significance was set at 95% (P = 0·05). Associa-
tions are presented as odds ratios (OR) with 95% confidence
intervals (95% CI). The statistical analysis was performed with
STATA Statistical Software (Release 10, College Station, TX, USA:
StataCorp LP 2007).
Results
From the entire cohort of 2401 patients in the ASTRAL registry
during the observation period, 203 patients were excluded
because of a prestroke mRS > 2 and 95 patients because the initial
imaging was performed >24 h after stroke onset. One hundred
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sixty-four patients were excluded because one or more of the six
components of the ASTRAL score were unavailable and 47
because three-month mRS was not available. Finally, 1892
patients [median age: 71·2 years, IQR: 59·4–79·8; 1094 (57·8%)
males] were available for analysis. Overall, 1855 (98·0%) had an
acute CT, 1626 (85·9%) had acute CTA, and 1268 (67·1%) had
PCT. A few patients had MRI as the initial imaging, and others
had a CT followed by MRI in the acute phase. Three hundred
eighty-one (20·1%) patients were treated with intravenous
thrombolysis and 31 (1·6%) with endovascular revascularization.
The baseline characteristics of the patients are summarized in
Table 1.
The AUC of the ASTRAL score in the overall population was
0·850, which is similar with the AUC of the score during the
analysis which introduced the ASTRAL score (11). When added to
the ASTRAL score in logistic regression analyses, the following
covariates were not significant predictors of three-month func-
tional outcome: any stroke-related acute lesion on CT or MRI, any
vascular lesions on acute CT or MRI not related to the current
stroke, significant arterial pathology in the ischemic territory,
significant intracranial arterial pathology in the ischemic terri-
tory, and focal hypoperfusion on PCT. There was no interaction
between any of the aforementioned covariates and time delay
since stroke onset.
In a logistic regression analysis including the ASTRAL score as
a covariate, significant extracranial arterial pathology in the isch-
emic territory on acute CTA or MRA or Doppler was an indepen-
dent predictor of three-month functional outcome (OR: 1·49,
95% CI: 1·08–2·05, P = 0·014). However, the AUC of the com-
bined model (which included both covariates) was similar to the
AUC of the ASTRAL score (0·849 vs. 0·850), which means that
significant extracranial arterial pathology does not increase sig-
nificantly the prognostic accuracy of the ASTRAL score (despite
being an independent predictor).
There were 1262 patients with an ASPECTS of 10, and 215
patients with an ASPECTS of <7. In a logistic regression analysis
including the ASTRAL score as a covariate, the ASPECTS – when
analyzed as a continuous covariate – was a significant predictor of
three-month functional outcome (OR: 0·93, 95% CI: 0·87–0·99,
P = 0·023). However, the AUC of the combined model (which
included both covariates) was similar to the AUC of the ASTRAL
score (0·8563 vs. 0·8564, P = 0·893), which means that the
ASPECTS (as a continuous covariate) does not increase signifi-
cantly the prognostic accuracy of the ASTRAL score (despite
being an independent predictor).
The ASPECTS was also analyzed as a categorical covariate using
different cutoff values (3, 5, 7, and 9) in a logistic regression
analysis including the ASTRAL score as a covariate. For the cutoffs
3 and 5, it was a significant predictor of three-month functional
outcome (OR: 2·32, 95% CI: 1·15–4·65, P = 0·018 and OR: 1·95,
95% CI: 1·21–3·12, P = 0·006, respectively). However, the AUC of
the combined model (which included both covariates) was
similar to the AUC of the ASTRAL score (0·857 vs. 0·856,
P = 0·318, for the cutoff value of 3; 0·857 vs. 0·856, P = 0·5695, for
the cutoff value of 5). For the cutoffs of 7 and 9, the ASPECTS was
not a significant predictor of three-month outcome.
In exploratory logistic regression analyses, to identify arbi-
trarily chosen subgroups of patients in which the addition
of imaging could increase the prognostic accuracy of the
ASTRAL score, no covariate was found to significantly increase
the prognostic accuracy of the ASTRAL score in any subgroup
(Table 2).
Table 1 Baseline characteristics of analyzed patients
Total number of eligible patients 1892
Median age (years) 71·2 (59·4–79·8)
Male gender 1094 (57·8%)
NIHSS at admission 6 (3–14)
Onset-to-admission time (minutes) 204 (93–624)
Prestroke mRS
0 1215 (64·3%)
1 472 (24·9%)
2 205 (10·8%)
Serum glucose at admission (mmol/l) 6·5 (5·7–7·7)
Blood pressure at admission (mmHg)
Systolic 157 (140–176)
Diastolic 89 (78–100)
Visual field deficit 635 (33·6%)
Decreased level of consciousness 200 (10·6%)
Stroke risk factors
Smoking* 460 (24·5%)
Hypertension† 1266 (67·1%)
Atrial fibrillation (AF)‡ 478 (25·3%)
Diabetes mellitus 312 (16·6%)
Dyslipidemia 1299 (68·8%)
Acute CT < 24 h of onset 1855 (98·0%)
Acute arterial imaging performed
Any vascular imaging 1695 (89·7%)
None 195 (10·3%)
CTA 1626 (85·9%)
MRA 66 (3·5%)
Doppler 333 (17·6%)
Perfusion CT performed 1268 (67·1%)
ASPECTS score on admission
10 1262 (67·8%)
7–9 383 (20·6%)
<7 215 (11·6%)
Stroke mechanism (TOAST classification)
Large-artery atherosclerotic stroke 265 (14·1%)
Cardioembolic stroke 624 (33·1%)
Lacunar stroke 263 (14·0%)
Stroke of other determined etiology 72 (3·8%)
Stroke of undetermined origin or multiple
etiologies
659 (35·0%)
Treatment
Intravenous thrombolysis 381 (20·1%)
Endovascular revascularization 31 (1·6%)
*Defined as current smoking or smoking stopped <2 years before the
stroke.
†Known or newly diagnosed hypertension.
‡Known history or newly diagnosed AF; patients with one single
episode of AF are not included.
Numbers represent medians and interquartile range for continuous
covariates, and absolute count and proportion for categorical
covariates.
ASPECTS, Alberta Stroke Program Early CT score; CT, computed
tomography; CTA, CT angiography; MRA, magnetic resonance
angiography; mRS, modified Rankin Scale score; NIHSS, National Insti-
tute of Health Stroke Scale score.
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Discussion
The present study analyzed a large series of previously indepen-
dent consecutive AIS patients and found that the addition of
readily available information derived from mostly CT-based MMI
does not increase the accuracy of the ASTRAL score to predict
three-month functional outcome despite the fact that certain
imaging parameters (i.e., the ASPECTS and the presence of
extracranial arterial pathology in the ischemic territory) had an
independent prognostic value.
The fact that the prognostic accuracy of the ASTRAL score did
not increase by the addition of information from (parenchymal,
vascular, and perfusion) MMI neither in the overall study popu-
lation nor in selected arbitrarily chosen patient subgroups, should
only be regarded as a further confirmation of the excellent per-
formance of the ASTRAL score, and, of course, by no means does
it suggest that acute imaging does not need to be performed
during acute stroke. The most plausible explanation for this
finding could be that most of the information derived from acute
MMI is already incorporated into (certain components of) the
ASTRAL score: there is a causal chain in acute ischemic stroke
which originates from the vascular lesion and predicts clinical
severity and imaging findings. The ASTRAL score gives consider-
able weight to the initial NIHSS and level of consciousness which
were previously shown to be closely associated with the presence
of acute intracranial arterial occlusions (30) and with the extent
of core and penumbra (10,31,32). Therefore, the clinical variables
included in the ASTRAL score may eliminate MMI radiological
covariates from being independent predictors, or make them of
little additive value. It may also be that we did not analyze suffi-
cient details of MMI, such as threshold-based volumes of nonvi-
able and at-risk tissue, site and extent of occlusion, or collaterals.
Also, it may be due to the fact that we did not target specific stroke
types but have analyzed a consecutive real-world AIS population.
Still, the analysis of defined subgroups within our population did
not improve the prognostic score either.
We found that the ASPECTS based on plain imaging and the
presence of significant extracranial arterial pathology on CTA/
MRA/Doppler were independent predictors of functional
outcome. These results confirm previous observations that the
ASPECTS [based on noncontrast CT (24)] and diffusion
weighted imaging (DWI) (33) are prognostic predictors indepen-
dently of clinical and epidemiological variables. Regarding other
parameters of MMI, we limited our analysis to readily available
parameters to avoid the additional time required for detailed
analysis and the sometimes difficult decisions of thresholds (34).
Doing so, the presence of any extracranial stenosis ≥50% or occlu-
sion was associated with worse three-month prognosis, but
intracranial arterial pathology or focal tissue hypoperfusion was
not. Other MMI parameters did not add independent informa-
tion in this consecutive AIS population. MMI in AIS has been
shown in some studies to add prognostic value in addition to
clinical parameters (8,10,35). Collateral status, which we did not
measure, was also an independent predictor in some studies
(36,37) as were certain threshold tissue viability parameters (10).
These MMI parameters which will require more time and exper-
tise to assess could be added in further similar studies. Moreover,
MMI was shown to predict response to revascularization treat-
ment in selected stroke patients and situations, such as mismatch
imaging in territorial infarct of the middle cerebral artery (MCA)
territory with visible hypoperfusion (38–41) or arterial imaging
in MCA strokes before thrombolysis (6); our study was not
designed to address the question of treatment response.
Strengths of the present study are the inclusion and analysis of
a large series of consecutive AIS over an eight-year period. Also,
we analyzed information derived from MMI (including vascular
and perfusion imaging) performed during the acute phase of
stroke (within 24 h after stroke onset). Moreover, this analysis was
performed on the same dataset which was used to develop the
ASTRAL score (11). Also, we tried several statistical analyses to
identify potential covariates which could increase the prognostic
accuracy of the ASTRAL score, e.g., the ASPECTS was analyzed
both as a continuous and a categorical covariate using different
cutoffs. Finally, we also analyzed several patient subgroups to
identify potential populations for which the addition of imaging
could increase the predictive accuracy of the ASTRAL score.
Limitations of the study are that information about the volume
of the initial infarct and the penumbra, the degree of vascular
stenosis, thrombus length in occlusions, and a clot burden score
were not available for the analysis. Also, information about col-
lateral circulation in patients with intracranial occlusions, which
was previously shown to predict stroke outcome (36,42), was not
available for the analysis. Therefore, it cannot be excluded that
more specific imaging may eventually increase the prognostic
accuracy of the ASTRAL score. Moreover, not all patients had
available all imaging examinations (i.e., parenchymal, vascular,
and perfusion brain imaging), which, however, would be impos-
sible to achieve given the large series of included patients and the
pragmatic real-world nature of this study. Finally, the present
analysis was performed in the same patient population which was
used to develop the ASTRAL score, which may have introduced
selection bias.
In conclusion, the ASTRAL score is a reliable tool to predict
three-month functional outcome in patients with AIS; further
studies are necessary to investigate whether collateral or penum-
bral imaging could increase its prognostic accuracy.
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